IGEN / IGEN Networks Corp. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

IGEN Networks Corp.
US ˙ OTCPK

Ações em Circulação 3,234,606,010 shares
Ações de Insider90,643,382 shares
Propriedade de Insider2.80 %
Total de Insiders5
Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Veja as Ações de Maior Classificação
Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Veja as Ações de Maior Classificação
Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

0 ( )
7481 out of 10948

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

0.000% ( )
7386 out of 10786

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

IGEN Networks Corp. negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider Lucro Médio (%) Ações
Possuídas		 Ajuste
de Divisão
Neil Gene Chan CEO, Director - [D] [O] 27,726,911 27,726,911
Insider Lucro Médio (%) Ações
Possuídas		 Ajuste
de Divisão
Richard Allan Freeman COO, Director - [D] [O] 474,900 474,900
Robert G Friedman Director, 10% Owner - [D] [10%] 50,000,000 50,000,000
Insider Lucro Médio (%) Ações
Possuídas		 Ajuste
de Divisão
Robert Nealon Director - [D] 2,271,571 2,271,571
Abel Israel Sr Sierra Vice President - [O] 10,170,000 10,170,000

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em IGEN / IGEN Networks Corp.. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custo Dias até
Máx		 Preço em
Máx		 Lucro
Máximo ($)		 Retorno Máximo (%)
2020-11-20 Chan Neil Gene 150,000 0.0051 150,000 0.0051 765 94 0.0216 2,475 323.53
2020-11-19 Chan Neil Gene 200,000 0.0055 200,000 0.0055 1,100
2020-11-18 Chan Neil Gene 150,000 0.0048 150,000 0.0048 720
2020-10-01 Chan Neil Gene 200,000 0.0080 200,000 0.0080 1,600
2020-09-30 Chan Neil Gene 200,000 0.0083 200,000 0.0083 1,660
2020-07-31 Chan Neil Gene 200,000 0.0074 200,000 0.0074 1,480
2020-06-03 Sierra Abel Israel Sr 10,000,000 0.0025 10,000,000 0.0025 25,000
2020-06-01 Chan Neil Gene 16,828,800 0.0025 16,828,800 0.0025 42,072
2020-04-17 Chan Neil Gene 500,000 0.0080 500,000 0.0080 4,000

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

IGEN / IGEN Networks Corp. Insider Trades
Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em IGEN / IGEN Networks Corp.. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação Insider Reported
Shares		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custo Dias até
Mín		 Preço em
Mín		 Máxima Perda
Evitada ($)		 Máxima Perda
Evitada (%)
2019-08-23 Chan Neil Gene 20,000 0.0450 20,000 0.0450 900 235 0.0006 -888 -98.67
2015-09-10 Chan Neil Gene 270,000 0.2100 270,000 0.2100 56,700

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

IGEN / IGEN Networks Corp. Insider Trades
Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo
Data		 Data da
Operação		 Formulário Insider Ticker Título de Segurança Código 10b5-1 Direto Preço de Exercício
Preço Unitário		 Preço por
Unidade		 Unidades
Alteradas		 Valor
Alterado (1K)		 Opções
Restantes		 Ações
Restantes
2020-11-23 2020-11-20 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0051 150,000 1 27,726,911
2020-11-23 2020-11-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0055 200,000 1 27,576,911
2020-11-23 2020-11-18 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0048 150,000 1 27,376,911
2020-10-01 2020-10-01 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0080 200,000 2 27,226,911
2020-10-01 2020-09-30 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0083 200,000 2 27,026,911
2020-07-31 2020-07-31 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0074 200,000 1 26,826,911
2020-06-04 2020-06-03 4 Sierra Abel Israel Sr IGEN Common Stock P - Purchase D 0.0025 10,000,000 25 10,170,000
2020-06-01 2020-06-01 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0025 16,828,800 42 26,626,911
2020-04-17 2020-04-17 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0080 500,000 4 9,798,111
2020-04-17 2020-04-16 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0090 500,000 4 9,298,111
2020-04-17 2020-04-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0070 2,000,000 14 8,798,111
2020-04-17 2020-04-14 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0070 1,000,000 7 6,798,111
2020-04-10 2020-04-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0010 1,000,000 1 5,798,111
2020-04-10 2020-04-08 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0012 500,000 1 4,798,111
2020-03-30 3 Friedman Robert G IGEN Common Stock D 50,000,000
2020-03-30 3 Friedman Robert G IGEN Common Stock D 50,000,000
2020-03-30 3 Friedman Robert G IGEN Common Stock D 50,000,000
2020-03-27 2020-02-13 5 Nealon Robert IGEN Common Stock P - Purchase D 0.0150 1,750,000 26 2,271,571
2020-03-23 2020-03-23 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0011 500,000 1 4,298,111
2020-03-23 2020-03-20 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0015 500,000 1 3,798,111
2020-02-24 2020-02-24 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0050 200,000 1 3,298,111
2020-02-24 2020-02-21 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0064 300,000 2 3,098,111
2020-02-24 2020-02-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0095 50,000 0 2,798,111
2020-02-24 2020-02-18 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0085 100,000 1 2,748,111
2020-02-13 2020-02-12 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0100 50,000 0 2,648,111
2020-02-13 2020-02-11 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0110 100,000 1 2,598,111
2020-02-13 2020-02-07 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0140 100,000 1 2,498,111
2020-02-13 2020-02-06 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0140 50,000 1 2,398,111
2019-12-20 2019-12-20 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0180 25,000 0 2,348,111
2019-12-20 2019-12-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0180 25,000 0 2,323,111
2019-12-20 2019-12-17 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0180 100,000 2 2,298,111
2019-12-20 2019-12-16 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0190 25,000 0 2,198,111
2019-12-13 2019-12-11 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0250 25,000 1 2,173,111
2019-12-13 2019-12-10 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0250 10,000 0 2,148,111
2019-12-13 2019-12-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0250 50,000 1 2,138,111
2019-12-05 2019-12-04 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.3100 25,000 8 2,088,111
2019-12-05 2019-12-03 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.3000 25,000 8 2,063,111
2019-11-20 2019-11-20 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0310 5,000 0 2,038,111
2019-11-20 2019-11-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0340 5,000 0 2,033,111
2019-11-20 2019-11-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0250 50,000 1 2,028,111
2019-11-20 2019-11-18 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0370 30,000 1 1,978,111
2019-10-31 2019-10-31 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0380 5,000 0 1,948,111
2019-10-31 2019-10-31 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0330 75,000 2 1,943,111
2019-10-31 2019-10-29 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0300 20,000 1 1,868,111
2019-10-31 2019-10-28 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 5,000 0 1,848,111
2019-08-29 2019-08-29 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0600 10,000 1 1,843,111
2019-08-29 2019-08-28 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0390 20,000 1 1,833,111
2019-08-26 2019-08-23 4 Chan Neil Gene IGEN Common Stock S - Sale D 0.0450 -20,000 -1 1,813,111
2019-08-26 2019-08-21 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 10,000 0 1,833,111
2019-02-22 2019-02-21 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 45,000 2 1,823,111
2019-02-22 2019-02-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0350 50,000 2 1,778,111
2019-02-22 2019-02-12 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 25,000 1 1,728,111
2019-02-22 2019-02-12 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 25,000 1 1,728,111
2019-01-17 2019-01-17 4 Chan Neil Gene TFSA Neil Chan IGEN Common Stock J - Other I 300,000 654,278
2019-01-17 2019-01-17 4 Chan Neil Gene IGEN Common Stock J - Other D -300,000 1,678,111
2019-01-10 2019-01-09 4 Chan Neil Gene TFSA Heather M. Chan IGEN Common Stock J - Other I 182,678 354,278
2019-01-10 2019-01-09 4 Chan Neil Gene TFSA Neil Chan IGEN Common Stock J - Other I 182,678 354,278
2019-01-10 2019-01-09 4 Chan Neil Gene IGEN Common Stock J - Other D -365,356 1,978,111
2018-11-13 2018-11-06 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0900 2,000 0 2,343,467
2018-11-13 2018-11-05 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0850 2,500 0 2,341,467
2018-11-13 2018-11-05 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0610 5,000 0 2,338,967
2018-11-08 2018-11-08 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0850 2,000 0 2,333,967
2018-11-08 2018-11-08 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0599 2,000 0 2,331,967
2018-11-08 2018-11-06 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0900 2,000 0 2,329,967
2018-11-08 2018-11-05 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0850 2,500 0 2,327,967
2018-11-08 2018-11-05 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0610 5,000 0 2,325,467
2018-10-12 2018-10-12 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0800 2,000 0 2,320,467
2018-10-12 2018-10-12 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0620 3,000 0 2,318,467
2018-08-31 2018-08-31 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0800 5,000 0 2,315,467
2018-08-31 2018-08-30 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0650 5,000 0 2,310,467
2018-08-17 2018-08-16 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 500 0 2,305,467
2018-08-17 2018-08-16 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0850 2,000 0 2,304,967
2018-08-17 2018-08-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0650 5,000 0 2,302,967
2018-08-17 2018-08-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0550 5,000 0 2,297,967
2018-08-10 2018-08-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0570 2,500 0 2,292,967
2018-08-10 2018-08-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 2,000 0 2,290,467
2018-08-10 2018-08-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0650 3,000 0 2,288,467
2018-08-10 2018-08-08 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0510 2,500 0 2,285,467
2018-08-10 2018-08-08 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0600 5,000 0 2,282,967
2018-07-20 2018-07-17 4 Sierra Abel Israel Sr IGEN Common Stock P - Purchase D 0.0400 20,000 1 170,000
2018-07-20 3 Sierra Abel Israel Sr IGEN Common Stock D 300,000
2018-07-20 3 Sierra Abel Israel Sr IGEN Common Stock D 300,000
2018-07-20 3 Sierra Abel Israel Sr IGEN Common Stock D 300,000
2018-07-17 2018-07-16 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0550 5,000 0 2,277,967
2018-06-29 2018-06-29 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 5,000 0 2,262,967
2018-06-29 2018-06-27 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 10,000 0 2,257,967
2018-06-20 2018-06-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0400 10,000 0 2,257,967
2018-04-06 2018-04-06 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1150 2,500 0 2,247,967
2018-04-06 2018-04-05 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0600 10,000 1 2,245,467
2018-03-26 2018-03-23 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0600 5,000 0 2,235,467
2018-03-26 2018-03-22 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0600 5,000 0 2,230,467
2018-03-26 2018-03-21 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1150 2,000 0 2,225,467
2018-01-22 2018-01-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0998 5,000 0 2,223,467
2018-01-12 2018-01-09 4 Chan Neil Gene TFSA Neil Chan IGEN Common Stock J - Other I 171,600 171,600
2018-01-12 2018-01-09 4 Chan Neil Gene TFSA Heather M. Chan IGEN Common Stock J - Other I 171,600 171,600
2018-01-12 2018-01-09 4 Chan Neil Gene IGEN Common Stock J - Other D -343,200 2,218,467
2018-01-12 2018-01-04 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1194 5,000 1 2,561,667
2018-01-12 2017-12-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 2,000 0 2,556,667
2018-01-12 2017-12-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 2,000 0 2,556,667
2018-01-12 2017-12-04 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1150 2,000 0 2,552,667
2018-01-12 2017-11-29 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1000 2,000 0 2,550,667
2018-01-12 2017-11-28 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1000 2,000 0 2,548,667
2017-09-22 2017-09-21 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0850 2,500 0 2,546,667
2017-09-22 2017-09-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1140 2,500 0 2,544,167
2017-09-22 2017-09-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0970 2,500 0 2,541,667
2017-09-19 2017-09-15 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0750 2,000 0 2,539,167
2017-09-19 2017-09-14 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0650 20,000 1 2,537,167
2017-09-19 2017-09-14 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 1,000 0 2,517,167
2017-09-19 2017-09-14 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0950 2,000 0 2,516,167
2017-09-06 2017-09-01 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0850 11,000 1 2,514,167
2017-09-06 2017-09-01 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1000 10,000 1 2,503,167
2017-06-20 2017-06-14 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1000 10,000 1 2,553,167
2017-05-19 2017-05-11 4 Freeman Richard Allan IGEN Options A - Award D 0.13 500,000 1,775,000
2017-05-19 2017-05-11 4 Chan Neil Gene IGEN Options A - Award D 0.13 500,000 1,500,000
2017-05-15 2017-05-11 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1300 6,000 1 2,543,167
2017-05-15 2017-05-10 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1300 4,000 1 2,549,167
2017-05-09 2017-04-18 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1300 5,000 1 2,548,167
2017-04-20 2017-04-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1400 2,500 0 2,553,167
2017-04-20 2017-04-19 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1230 2,500 0 2,550,667
2017-01-20 2017-01-18 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0950 5,000 0 2,523,167
2017-01-20 2017-01-18 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1000 5,000 0 2,518,167
2017-01-13 2017-01-09 4 Chan Neil Gene IGEN Common P - Purchase D 0.0600 25,000 2 2,513,167
2017-01-13 2017-01-06 4 Chan Neil Gene IGEN Common P - Purchase D 0.0749 10,000 1 2,488,167
2016-12-16 2016-12-12 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0700 10,000 1 2,478,167
2016-12-16 2016-12-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.1000 10,000 1 2,468,167
2016-10-05 2016-09-26 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0910 25,000 2 2,458,167
2016-07-20 2016-07-12 4 Chan Neil Gene IGEN Common P - Purchase D 0.1380 5,000 1 2,433,167
2016-05-12 2016-05-05 4 Chan Neil Gene IGEN Common P - Purchase D 0.1550 10,000 2 2,428,167
2016-02-25 2016-02-12 4 Chan Neil Gene IGEN Common P - Purchase D 0.1800 10,000 2 2,418,167
2016-02-25 2016-02-10 4 Chan Neil Gene IGEN Common P - Purchase D 0.1780 10,000 2 2,408,167
2016-02-25 2016-02-09 4 Chan Neil Gene IGEN Common P - Purchase D 0.1740 10,000 2 2,398,167
2016-02-25 2016-01-07 4 Chan Neil Gene IGEN Options M - Exercise D 0.09 0.0900 -55,556 -5 0
2016-02-25 2016-01-07 4 Chan Neil Gene IGEN Common M - Exercise D 0.0900 55,556 5 2,388,167
2015-10-07 2015-09-21 4 Nealon Robert IGEN Options A - Award D 0.19 250,000 250,000
2015-10-02 2015-09-21 4 Freeman Richard Allan IGEN Options A - Award D 0.19 1,000,000 1,000,000
2015-10-02 2015-09-21 4 Chan Neil Gene IGEN Options A - Award D 0.19 1,000,000 1,000,000
2015-09-14 2015-09-10 4 Chan Neil Gene IGEN Common Stock S - Sale D 0.2100 -270,000 -57 2,332,611
2015-09-14 2015-09-10 4 Chan Neil Gene IGEN Common Stock P - Purchase D 0.2500 5,500 1 2,602,611
2014-04-15 2014-03-05 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0800 25,000 2 249,900
2014-04-15 2014-03-03 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0650 5,000 0 224,900
2014-04-15 2014-02-28 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0650 52,000 3 219,900
2014-04-15 2014-02-27 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0650 25,000 2 167,900
2014-04-15 2014-02-27 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0650 5,000 0 142,900
2014-04-15 2014-01-27 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0900 9,000 1 137,900
2014-04-15 2014-01-14 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0950 10,000 1 128,900
2014-04-15 2013-12-13 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1050 6,000 1 118,900
2014-04-15 2013-12-04 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1100 5,500 1 112,900
2014-04-15 2013-12-02 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1200 10,000 1 107,400
2014-04-15 2013-11-29 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1300 5,000 1 97,400
2014-04-15 2013-11-27 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1300 5,000 1 92,400
2014-04-15 2013-11-27 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.0950 5,000 0 87,400
2014-04-15 2013-11-26 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1030 10,000 1 82,400
2014-04-15 2013-11-22 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1000 10,000 1 72,400
2014-04-15 2013-10-11 5 Freeman Richard Allan IGEN Stock Option C - Conversion D 0.09 0.0900 -225,000 -20 275,000
2014-04-15 2013-10-11 5 Freeman Richard Allan IGEN Common Stock C - Conversion D 0.0900 225,000 20 474,900
2014-04-15 2013-03-25 5 Freeman Richard Allan IGEN Stock Option A - Award D 0.09 0.0900 500,000 45 500,000
2014-04-15 2012-11-02 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1000 4,998 0 62,400
2014-04-15 2012-10-26 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1000 5,000 0 57,402
2014-04-15 2012-10-16 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1290 5,500 1 42,402
2014-04-15 2012-10-16 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1250 5,000 1 36,902
2014-04-15 2012-10-16 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1230 11,900 1 31,902
2014-04-15 2012-10-15 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1300 10,000 1 52,402
2014-04-15 2012-10-15 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1000 2 0 20,002
2014-04-15 2012-09-12 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1500 10,000 2 20,000
2014-04-15 2012-09-12 5 Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership IGEN Common Stock P - Purchase I 0.1700 10,000 2 10,000
2014-04-15 2014-02-28 5 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0650 21,000 1 2,597,111
2014-04-15 2014-02-27 5 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0650 70,000 5 2,576,111
2014-04-15 2013-11-04 5 Chan Neil Gene IGEN Stock Option C - Conversion D 0.09 0.0900 -325,000 -29 55,556
2014-04-15 2013-11-04 5 Chan Neil Gene IGEN Common Stock C - Conversion D 0.0900 325,000 29 2,506,111
2014-04-15 2013-08-01 5 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0895 10,000 1 2,181,111
2014-04-15 2013-07-31 5 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0895 13,000 1 2,171,111
2014-04-15 2013-07-30 5 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0995 12,000 1 2,156,111
2014-04-15 2013-07-29 5 Chan Neil Gene IGEN Common Stock P - Purchase D 0.0833 15,000 1 2,146,111
2014-04-15 2013-03-26 4/A Chan Neil Gene IGEN Options M - Exercise D 0.09 0.0900 -444,444 -40 380,556
2014-04-15 2013-03-26 4/A Chan Neil Gene IGEN Common Stock M - Exercise D 0.0900 444,444 40 2,131,111
2014-04-15 2013-03-25 4/A Chan Neil Gene IGEN Options A - Award D 0.09 0.0900 825,000 74 825,000
2013-04-11 2013-03-26 4 Chan Neil Gene Shares owned by shareholders company IGEN Options M - Exercise I 0.09 0.0900 -444,444 -40 55,556
2013-04-11 2013-03-26 4 Chan Neil Gene Shares owned by shareholders' company IGEN Common Stock M - Exercise I 0.0900 444,444 40 444,444
2013-03-19 2013-03-18 4 Chan Neil Gene IGEN Common Stock A - Award D 1,666,667 1,686,667
2012-08-03 2012-07-09 4 Chan Neil Gene IGEN Common Stock P - Purchase D 5,999.1500 20,000 119,983 20,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista

© 2015-2026 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.

About Fintel
Features
Explore
Help Center